Exhibitor

Curetis USA is focused on delivering fast, reliable and cost-effective molecular solutions to aid in diagnosing severe infectious diseases. Now FDA approved, Curetis’ Unyvero™ system provides U.S. clinicians with rapid and critical information for the early detection of microorganisms and resistance markers associated with lower respiratory tract infections.